Literature DB >> 1649037

Mechanisms in TGF-beta action.

J Massagué1, J Heino, M Laiho.   

Abstract

The various isoforms of TGF-beta are multifunctional. We are exploring pathways of cellular regulation by TGF-beta that lead to suppression of cell proliferation, modulation of cell adhesion and control of cell differentiation. These cellular responses appear to be activated by binding of TGF-beta to a similar set of receptor glycoproteins in all cell types. TGF-beta receptor types I and II are specifically lost in cell mutants that are resistant to TGF-beta. The concomitant loss of these two receptors in certain mutants suggests that they are components of the TGF-beta signal-transducing receptor complex. Inhibition of epithelial cell proliferation by TGF-beta is linked to retention of the retinoblastoma growth suppressor gene product in an underphosphorylated state that is presumed to have growth suppressive activity. Inhibition of myogenic differentiation by TGF-beta involves a block in the expression of the master myogenic differentiation genes, such as myogenin, but appears also to involve up-regulation of extracellular matrix production. Expression of components of the cell adhesion apparatus--cell adhesion receptors and extracellular matrix proteins--is controlled by TGF-beta in an array of cell types. This response could have a great impact on the ability of cells to migrate, home to specific tissue locations and differentiate during development, invasion and metastasis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649037     DOI: 10.1002/9780470514061.ch4

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  8 in total

1.  TGF-beta 1 reverses PDGF-stimulated migration of human aortic smooth muscle cells in vitro.

Authors:  L Engel; U Ryan
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-06       Impact factor: 2.416

2.  GDF3 inhibits the growth of breast cancer cells and promotes the apoptosis induced by Taxol.

Authors:  Qiang Li; Yichen Ling; Long Yu
Journal:  J Cancer Res Clin Oncol       Date:  2012-04-10       Impact factor: 4.553

3.  A novel interaction between megakaryocytes and activated fibrocytes increases TGF-β bioavailability in the Gata1(low) mouse model of myelofibrosis.

Authors:  Maria Zingariello; Alessandra Ruggeri; Fabrizio Martelli; Manuela Marra; Laura Sancillo; Ilaria Ceglia; Rosa Alba Rana; Anna Rita Migliaccio
Journal:  Am J Blood Res       Date:  2015-12-25

4.  TGF-{beta} maintains dormancy of prostatic stem cells in the proximal region of ducts.

Authors:  Sarah N Salm; Patricia E Burger; Sandra Coetzee; Ken Goto; David Moscatelli; E Lynette Wilson
Journal:  J Cell Biol       Date:  2005-06-27       Impact factor: 10.539

5.  TGF-β triggers rapid fibrillogenesis via a novel TβRII-dependent fibronectin-trafficking mechanism.

Authors:  Archana Varadaraj; Laura M Jenkins; Priyanka Singh; Anindya Chanda; John Snider; N Y Lee; Ayelet R Amsalem-Zafran; Marcelo Ehrlich; Yoav I Henis; Karthikeyan Mythreye
Journal:  Mol Biol Cell       Date:  2017-03-15       Impact factor: 4.138

6.  Development of a primary melanoma in situ within a full-thickness skin graft overlying a free muscle flap: a case report.

Authors:  Robert J Dabek; Nemanja Baletic; Harrison McUmber; Brian Nahed; Alex Haynes; Kyle R Eberlin; Branko Bojovic
Journal:  Case Reports Plast Surg Hand Surg       Date:  2018-04-06

7.  Biosynthesis and in vivo localization of the decapentaplegic-Vg-related protein, DVR-6 (bone morphogenetic protein-6).

Authors:  N A Wall; M Blessing; C V Wright; B L Hogan
Journal:  J Cell Biol       Date:  1993-01       Impact factor: 10.539

8.  Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions.

Authors:  M Blessing; P Schirmacher; S Kaiser
Journal:  J Cell Biol       Date:  1996-10       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.